CIK: 1752940 - Address: C/O Y-Mabs Therapeutics, Inc., 230 Park Avenue, Suite 3350, New York, NY 10169
22 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
5/31/24 21:36
5/30/24
YMABY-Mabs Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsKruse BoNYOEVP,CFO,M.dm1202.0006040211D
5/31/24 21:36
5/30/24
YMABY-Mabs Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsKruse BoNYOEVP,CFO,S.dm-72312.050-60-22211D
2/23/22 17:15
2/22/22
YMABY-Mabs Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsKruse BoNYOEVP,CFO,S-317.850-4-2181D
2/7/22 17:16
2/4/22
YMABY-Mabs Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsKruse BoNYOEVP,CFO,S-327.970-4-2185D
1/25/22 17:01
1/24/22
YMABY-Mabs Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsKruse BoNYOEVP,CFO,S-399.840-4-2189D
1/5/22 17:15
1/4/22
YMABY-Mabs Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsKruse BoNYOEVP,CFO,S-6817.120-4-2193D
12/23/21 16:55
12/22/21
YMABY-Mabs Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsKruse BoNYOEVP,CFO,S-6516.360-4-2197D
12/7/21 17:16
12/6/21
YMABY-Mabs Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsKruse BoNYOEVP,CFO,S-6516.350-4-2201D
11/23/21 17:06
11/22/21
YMABY-Mabs Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsKruse BoNYOEVP,CFO,S-7218.090-4-2205D
11/5/21 17:16
11/4/21
YMABY-Mabs Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsKruse BoNYOEVP,CFO,S-11027.540-4-2209D
10/26/21 18:04
10/22/21
YMABY-Mabs Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsKruse BoNYOEVP,CFO,S-10425.940-4-2213D
10/5/21 17:16
10/4/21
YMABY-Mabs Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsKruse BoNYOEVP,CFO,S-11528.780-4-2217D
9/23/21 17:15
9/22/21
YMABY-Mabs Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsKruse BoNYOEVP,CFO,S-12330.820-4-2221D
9/8/21 17:31
9/7/21
YMABY-Mabs Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsKruse BoNYOEVP,CFO,S-12832.030-4-2225D
8/24/21 17:02
8/23/21
YMABY-Mabs Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsKruse BoNYOEVP,CFO,S-11428.600-4-2229D
8/5/21 17:20
8/4/21
YMABY-Mabs Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsKruse BoNYOEVP,CFO,S-13533.720-4-2233D
7/26/21 06:19
7/22/21
YMABY-Mabs Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsKruse BoNYOEVP,CFO,S-13834.500-4-2237D
7/7/21 18:00
7/6/21
YMABY-Mabs Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsKruse BoNYOEVP,CFO,S-13734.150-4-2241D
6/23/21 16:30
6/22/21
YMABY-Mabs Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsKruse BoNYOEVP,CFO,S-14536.170-4-2245D
6/7/21 16:30
6/4/21
YMABY-Mabs Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsKruse BoNYOEVP,CFO,S-13433.480-4-2249D
5/26/21 16:33
5/24/21
YMABY-Mabs Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsKruse BoNYOEVP,CFO,S-14235.610-4-2253D
5/15/20 16:15
5/13/20
YMABY-Mabs Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsKruse BoNYOEVP,CFO,S.m-3,66536.650-100-28257M

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact